Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) provides a fully integrated Clinical Research Organization (CRO) that creates value by collecting and presenting evidence for the entire commercialization process, from regulatory approval to reimbursement, for emerging technologies.
MCRA’s clients range from medical device startups to the largest publicly traded medical device companies. Our exclusive focus on neuro-musculoskeletal devices and therapies sets us apart from other CROs.
Since MCRA’s establishment in 2004, the Clinical Research Organization (CRO) has been involved in designing and/or executing more than 50 clinical studies. MCRA streamlines the clinical trial process by utilizing a unique, integrated approach to achieve faster enrollment and higher FDA approval rates. Our in-house orthopedic expertise and global network of surgeons makes MCRA a valuable clinical research partner that will assist you in getting to market on time and on budget.